{"id":573068,"date":"2025-01-31T00:00:00","date_gmt":"2025-01-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0184-biopharma-binge-eating-disorder-epidemiology-mature-markets\/"},"modified":"2026-03-31T10:27:12","modified_gmt":"2026-03-31T10:27:12","slug":"epidcg0184-biopharma-binge-eating-disorder-epidemiology-mature-markets","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0184-biopharma-binge-eating-disorder-epidemiology-mature-markets\/","title":{"rendered":"Binge Eating Disorder &#8211; Epidemiology &#8211; Mature Markets"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of binge eating disorder (<abbr title=\"binge-eating disorder\">BED<\/abbr>) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of <abbr title=\"binge-eating disorder\">BED<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets covered in this report.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"binge-eating disorder\">BED<\/abbr> forecast will answer the following question:<\/p>\n<ul class=\"round-bullets\">\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"binge-eating disorder\">BED<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS<\/span> Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts 10 <abbr title=\"binge-eating disorder\">BED<\/abbr> patient populations, as follows:<\/p>\n<ul class=\"round-bullets\">\n<li>Total lifetime prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total 12-month prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total lifetime prevalent cases of mild <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total lifetime prevalent cases of moderate <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total lifetime prevalent cases of severe <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total lifetime prevalent cases of extreme <abbr title=\"binge-eating disorder\">BED<\/abbr>.<\/li>\n<li>Total lifetime prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr> with depression.<\/li>\n<li>Total lifetime prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr> with anxiety disorder.<\/li>\n<li>Total lifetime prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr> with bipolar disorder.<\/li>\n<li>Total lifetime prevalent cases of <abbr title=\"binge-eating disorder\">BED<\/abbr> with attention-deficit\/hyperactivity disorder.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-573068","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-psychiatry","biopharma-product-epidemiology","biopharma-date-2297"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/573068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/573068\/revisions"}],"predecessor-version":[{"id":573274,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/573068\/revisions\/573274"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=573068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}